AstraZeneca’s Ultomiris misses primary endpoint in adult HSCT-TMA trial



[
AstraZeneca’s Ultomiris misses primary endpoint in adult HSCT-TMA trial
[og_img]
https://www.investing.com/news/company-news/astrazenecas-ultomiris-misses-primary-endpoint-in-adult-hscttma-trial-93CH-4813036


Investing.com

Latest articles

spot_imgspot_img

Related articles

Leave a reply

Please enter your comment!
Please enter your name here

spot_imgspot_img